A Study of Pazopanib Safety and Efficacy in Patients With Advanced Clear Cell Renal Cell Carcinoma and ECOG Performance Status 2 (Pazo2): An Open label, Multicentre, Single Arm, Phase II Trial
Titel:
A Study of Pazopanib Safety and Efficacy in Patients With Advanced Clear Cell Renal Cell Carcinoma and ECOG Performance Status 2 (Pazo2): An Open label, Multicentre, Single Arm, Phase II Trial
Auteur:
Zarkar, Anjali Pirrie, Sarah Stubbs, Clive Hodgkins, Anne-Marie Farrugia, David Fife, Kathryn MacDonald-Smith, Carey Vasudev, Naveen Porfiri, Emilio